By: Ed Mahon
HARRISBURG — Members of Pennsylvania’s Medical Marijuana Advisory Board are publicly questioning the Wolf administration’s oversight of doctors and third-party certification companies, concerns that echo a yearlong Spotlight PA investigation into the state’s program.
During the most recent advisory board meeting in November, health department officials faced scrutiny over the rigor of telemedicine appointments for medical marijuana card approvals and advertising by medical marijuana businesses.
Subscribe and stay updated
Receive our latest blog posts by email.
